Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

Biolinerx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Biolinerx (BLRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Barclays says AI trade is maturing, favors greater diversification
• Arrive AI and DXC Technology partner to bring delivery tech to factories